"The U.S. Food and Drug Administration today approved Vimizim (elosulfase alfa), the first FDA-approved treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome). Morquio A syndrome is a rare, autosomal recessive lysosomal storage disease "...
IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
TRIMETHOBENZAMIDE - ORAL
COMMON BRAND NAME(S): Tigan
USES: This medication is used to treat nausea and vomiting that can occur following surgery or with certain stomach/intestinal problems (e.g., gastroenteritis). Treating vomiting quickly can prevent a serious loss of body water (dehydration). Trimethobenzamide belongs to a class of drugs known as antiemetics. It works by decreasing the signals in the brain that lead to vomiting.
HOW TO USE: Take this medication by mouth, usually 3-4 times daily as needed or as directed by your doctor.
Dosage is based on your medical condition, age, and response to therapy. Take this medication exactly as directed to get the most benefit from it. Do not take more medication or take it more often than prescribed. Ask your doctor or pharmacist if you have questions.
Inform your doctor if your condition persists or worsens.
Additional Tigan Information
Tigan - User Reviews
Tigan User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.